Skip to main content
Top
Published in: Discover Oncology 4/2010

01-08-2010

Gene Expression Profiling Reveals Differentially Expressed Genes in Ovarian Cancer of the Hen: Support for Oviductal Origin?

Authors: Lindsey S. Treviño, James R. Giles, Wei Wang, Mary Ellen Urick, Patricia Ann Johnson

Published in: Discover Oncology | Issue 4/2010

Login to get access

Abstract

Ovarian cancer has a high mortality rate due, in part, to the lack of early detection and incomplete understanding of the origin of the disease. The hen is the only spontaneous model of ovarian cancer and can therefore aid in the identification and testing of early detection strategies and therapeutics. Our aim was to combine the use of the hen animal model and microarray technology to identify differentially expressed genes in ovarian tissue from normal hens compared with hens with ovarian cancer. We found that the transcripts up-regulated in chicken ovarian tumors were enriched for oviduct-related genes. Quantitative real-time PCR and immunohistochemistry confirmed expression of oviduct-related genes in normal oviduct and in ovaries from hens with early- and late-stage ovarian tumors, but not in normal ovarian surface epithelium. In addition, one of the oviduct-related genes identified in our analysis, paired box 2 has been implicated in human ovarian cancer and may serve as a marker of the disease. Furthermore, estrogen receptor 1 mRNA is over-expressed in early-stage tumors, suggesting that expression of the oviduct-related genes may be regulated by estrogen. We have also identified oviduct-related genes that encode secreted proteins that could represent putative serum biomarkers. The expression of oviduct-related genes in early-stage tumors is similar to what is seen in human ovarian cancer, with tumors resembling normal Müllerian epithelium. These data suggest that chicken ovarian tumors may arise from alternative sites, including the oviduct.
Appendix
Available only for authorised users
Literature
2.
go back to reference Konstatinopoulos PA, Spentzos D, Camistra SA (2008) Gene-expression profiling in epithelial ovarian cancer. Nat Clin Pract Oncol 5:577–587CrossRef Konstatinopoulos PA, Spentzos D, Camistra SA (2008) Gene-expression profiling in epithelial ovarian cancer. Nat Clin Pract Oncol 5:577–587CrossRef
4.
go back to reference Rodriguez-Burford C, Barnes MN, Berry W et al (2001) Immunohistochemical expression of molecular markers in an avian model: a potential model for preclinical evaluation of agents for ovarian cancer chemoprevention. Gynecol Oncol 81:373–379CrossRefPubMed Rodriguez-Burford C, Barnes MN, Berry W et al (2001) Immunohistochemical expression of molecular markers in an avian model: a potential model for preclinical evaluation of agents for ovarian cancer chemoprevention. Gynecol Oncol 81:373–379CrossRefPubMed
5.
go back to reference Urick ME, Johnson PA (2006) Cyclooxygenase 1 and 2 mRNA and protein expression in the Gallus domesticus model of ovarian cancer. Gynecol Oncol 103:673–678CrossRefPubMed Urick ME, Johnson PA (2006) Cyclooxygenase 1 and 2 mRNA and protein expression in the Gallus domesticus model of ovarian cancer. Gynecol Oncol 103:673–678CrossRefPubMed
6.
go back to reference Hales DB, Zhuge Y, Lagman JA et al (2008) Cyclooxygenases expression and distribution in the normal ovary and their role in ovarian cancer in the domestic hen (Gallus domesticus). Endocr 33:235–244CrossRef Hales DB, Zhuge Y, Lagman JA et al (2008) Cyclooxygenases expression and distribution in the normal ovary and their role in ovarian cancer in the domestic hen (Gallus domesticus). Endocr 33:235–244CrossRef
7.
go back to reference Urick ME, Giles JR, Johnson PA (2008) VEGF expression and the effect of NSAIDs on ascites cell proliferation in the hen model of ovarian cancer. Gynecol Oncol 110:418–424CrossRefPubMed Urick ME, Giles JR, Johnson PA (2008) VEGF expression and the effect of NSAIDs on ascites cell proliferation in the hen model of ovarian cancer. Gynecol Oncol 110:418–424CrossRefPubMed
8.
go back to reference Ansenberger K, Zhuge Y, Lagman JA et al (2009) E-cadherin expression in ovarian cancer in the laying hen, Gallus domesticus, compared to human ovarian cancer. Gynecol Oncol 113:362–369CrossRefPubMed Ansenberger K, Zhuge Y, Lagman JA et al (2009) E-cadherin expression in ovarian cancer in the laying hen, Gallus domesticus, compared to human ovarian cancer. Gynecol Oncol 113:362–369CrossRefPubMed
9.
go back to reference Hakim AA, Barry CP, Barnes HJ et al (2009) Ovarian adenocarcinomas in the laying hen and women share similar alterations in p53, ras, and HER-2/neu. Cancer Prev Res 2:114–121CrossRef Hakim AA, Barry CP, Barnes HJ et al (2009) Ovarian adenocarcinomas in the laying hen and women share similar alterations in p53, ras, and HER-2/neu. Cancer Prev Res 2:114–121CrossRef
10.
go back to reference Barua A, Bitterman P, Abramowicz JS et al (2009) Histopathology of ovarian tumors in laying hens: a preclinical model of human ovarian cancer. Int J Gynecol Cancer 19:531–539CrossRefPubMed Barua A, Bitterman P, Abramowicz JS et al (2009) Histopathology of ovarian tumors in laying hens: a preclinical model of human ovarian cancer. Int J Gynecol Cancer 19:531–539CrossRefPubMed
11.
go back to reference Urick ME, Giles JR, Johnson PA (2009) Dietary aspirin decreases the stage of ovarian cancer in the hen. Gynecol Oncol 112:166–170CrossRefPubMed Urick ME, Giles JR, Johnson PA (2009) Dietary aspirin decreases the stage of ovarian cancer in the hen. Gynecol Oncol 112:166–170CrossRefPubMed
12.
go back to reference Dennis G Jr, Sherman BT, Hosack DA et al (2003) DAVID: database for annotation, visualization, and integrated discovery. Genome Biol 4:P3CrossRefPubMed Dennis G Jr, Sherman BT, Hosack DA et al (2003) DAVID: database for annotation, visualization, and integrated discovery. Genome Biol 4:P3CrossRefPubMed
13.
go back to reference Huang DW, Sherman BT, Lempicki RA (2009) Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Nat Protoc 4:44–57CrossRef Huang DW, Sherman BT, Lempicki RA (2009) Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Nat Protoc 4:44–57CrossRef
14.
go back to reference Abdel Mageed AM, Isobe N, Yoshimura Y (2008) Expression of avian β-defensins in the oviduct and effects of lipopolysaccharide on their expression in the vagina of hens. Poult Sci 87:979–984CrossRef Abdel Mageed AM, Isobe N, Yoshimura Y (2008) Expression of avian β-defensins in the oviduct and effects of lipopolysaccharide on their expression in the vagina of hens. Poult Sci 87:979–984CrossRef
16.
17.
go back to reference Kobayashi A, Behringer RR (2003) Developmental genetics of the female reproductive tract in mammals. Nat Rev Genet 4:969–980CrossRefPubMed Kobayashi A, Behringer RR (2003) Developmental genetics of the female reproductive tract in mammals. Nat Rev Genet 4:969–980CrossRefPubMed
18.
go back to reference Auersperg N, Wong AS, Choi KC et al (2001) Ovarian surface epithelium: biology, endocrinology, and pathology. Endocr Rev 22:255–288CrossRefPubMed Auersperg N, Wong AS, Choi KC et al (2001) Ovarian surface epithelium: biology, endocrinology, and pathology. Endocr Rev 22:255–288CrossRefPubMed
19.
go back to reference Dubeau L (1999) The cell of origin of ovarian epithelial tumors and the ovarian surface epithelium dogma: does the emperor have no clothes? Gynecol Oncol 72:437–442CrossRefPubMed Dubeau L (1999) The cell of origin of ovarian epithelial tumors and the ovarian surface epithelium dogma: does the emperor have no clothes? Gynecol Oncol 72:437–442CrossRefPubMed
20.
21.
go back to reference Jarboe EA, Folkins AK, Drapkin R et al (2008) Tubal and ovarian pathways to pelvic epithelial cancer: a pathological perspective. Histopathology 53:127–138CrossRefPubMed Jarboe EA, Folkins AK, Drapkin R et al (2008) Tubal and ovarian pathways to pelvic epithelial cancer: a pathological perspective. Histopathology 53:127–138CrossRefPubMed
22.
go back to reference Karst AM, Drapkin R (2010) Ovarian cancer pathogenesis: a model in evolution. J Oncol 2010:932371PubMed Karst AM, Drapkin R (2010) Ovarian cancer pathogenesis: a model in evolution. J Oncol 2010:932371PubMed
23.
go back to reference IeM S, Kurman RJ (2004) Ovarian tumorigenesis: a proposed model based on morphological and molecular genetic analysis. Am J Pathol 164:1511–1518 IeM S, Kurman RJ (2004) Ovarian tumorigenesis: a proposed model based on morphological and molecular genetic analysis. Am J Pathol 164:1511–1518
24.
go back to reference Tong G, Chiriboga L, Hamele-Bena D et al (2007) Expression of PAX2 in papillary serous carcinoma of the ovary: immunohistochemical evidence of fallopian tube or secondary Müllerian system origin? Mod Pathol 20:856–863CrossRefPubMed Tong G, Chiriboga L, Hamele-Bena D et al (2007) Expression of PAX2 in papillary serous carcinoma of the ovary: immunohistochemical evidence of fallopian tube or secondary Müllerian system origin? Mod Pathol 20:856–863CrossRefPubMed
25.
go back to reference Tung CS, Mok SC, Tsang YTM (2009) PAX2 expression in low malignant potential ovarian tumors and low-grade ovarian serous carcinomas. Mod Pathol 22:1243–1250CrossRefPubMed Tung CS, Mok SC, Tsang YTM (2009) PAX2 expression in low malignant potential ovarian tumors and low-grade ovarian serous carcinomas. Mod Pathol 22:1243–1250CrossRefPubMed
26.
go back to reference Zhai QJ, Azcan A, Hamilton C et al (2010) PAX2 expression in non-neoplastic, primary neoplastic and metastatic neoplastic tissue: a comprehensive immunohistochemical study. Appl Immunohistochem Mol Morphol 18:323–332CrossRefPubMed Zhai QJ, Azcan A, Hamilton C et al (2010) PAX2 expression in non-neoplastic, primary neoplastic and metastatic neoplastic tissue: a comprehensive immunohistochemical study. Appl Immunohistochem Mol Morphol 18:323–332CrossRefPubMed
27.
go back to reference Muratovska A, Zhou C, He S et al (2003) Paired-box genes are frequently expressed in cancer and often required for cancer cell survival. Oncogene 22:7989–7997CrossRefPubMed Muratovska A, Zhou C, He S et al (2003) Paired-box genes are frequently expressed in cancer and often required for cancer cell survival. Oncogene 22:7989–7997CrossRefPubMed
28.
go back to reference Bowen NJ, Logani S, Dickerson EB et al (2007) Emerging roles for PAX8 in ovarian cancer and endosalpingeal development. Gynecol Oncol 104:331–337CrossRefPubMed Bowen NJ, Logani S, Dickerson EB et al (2007) Emerging roles for PAX8 in ovarian cancer and endosalpingeal development. Gynecol Oncol 104:331–337CrossRefPubMed
29.
go back to reference Dougherty DC, Sanders MM (2005) Estrogen action: revitalization of the chick oviduct model. Trends Endocrinol Metab 16:414–419CrossRefPubMed Dougherty DC, Sanders MM (2005) Estrogen action: revitalization of the chick oviduct model. Trends Endocrinol Metab 16:414–419CrossRefPubMed
30.
go back to reference Palmiter RD (1972) Regulation of protein synthesis in chick oviduct. J Biol Chem 247:6450–6461PubMed Palmiter RD (1972) Regulation of protein synthesis in chick oviduct. J Biol Chem 247:6450–6461PubMed
31.
go back to reference Wu H, Chen Y, Liang J et al (2005) Hypomethylation-linked activation of PAX2 mediates tamoxifen-stimulated endometrial carcinogenesis. Nature 438:981–987CrossRefPubMed Wu H, Chen Y, Liang J et al (2005) Hypomethylation-linked activation of PAX2 mediates tamoxifen-stimulated endometrial carcinogenesis. Nature 438:981–987CrossRefPubMed
32.
go back to reference Shang Y (2006) Molecular mechanisms of oestrogen and SERMs in endometrial carcinogenesis. Nat Rev Cancer 6:360–368CrossRefPubMed Shang Y (2006) Molecular mechanisms of oestrogen and SERMs in endometrial carcinogenesis. Nat Rev Cancer 6:360–368CrossRefPubMed
33.
go back to reference Cunat S, Hoffmann P, Pujol P (2004) Estrogens and epithelial ovarian cancer. Gynecol Oncol 94:25–32CrossRefPubMed Cunat S, Hoffmann P, Pujol P (2004) Estrogens and epithelial ovarian cancer. Gynecol Oncol 94:25–32CrossRefPubMed
34.
go back to reference Jacobs I, Bast RC Jr (1989) The CA125 tumor-associated antigen: a review of the literature. Hum Reprod 4:1–12PubMed Jacobs I, Bast RC Jr (1989) The CA125 tumor-associated antigen: a review of the literature. Hum Reprod 4:1–12PubMed
35.
go back to reference Drapkin R, von Horsten HH, Lin Y et al (2005) Human epididymis protein 4 (HE4) is a secreted glycoprotein that is overexpressed by serous and endometrioid ovarian carcinomas. Cancer Res 65:2162–2169CrossRefPubMed Drapkin R, von Horsten HH, Lin Y et al (2005) Human epididymis protein 4 (HE4) is a secreted glycoprotein that is overexpressed by serous and endometrioid ovarian carcinomas. Cancer Res 65:2162–2169CrossRefPubMed
36.
go back to reference Woo MMM, Gilks CB, Verhage HG et al (2004) Oviductal glycoprotein, a new differentiation-based indicator present in early ovarian epithelial neoplasia and cortical inclusion cysts. Gynecol Oncol 94:315–319CrossRef Woo MMM, Gilks CB, Verhage HG et al (2004) Oviductal glycoprotein, a new differentiation-based indicator present in early ovarian epithelial neoplasia and cortical inclusion cysts. Gynecol Oncol 94:315–319CrossRef
37.
go back to reference Maines-Bandiera S, Woo MMM, Borrugian M et al (2010) Oviductal glycoprotein (OVGP1, MUC9): a differentiation-based mucin present in serum of women with ovarian cancer. Int J Gynecol Cancer 20:16–22CrossRefPubMed Maines-Bandiera S, Woo MMM, Borrugian M et al (2010) Oviductal glycoprotein (OVGP1, MUC9): a differentiation-based mucin present in serum of women with ovarian cancer. Int J Gynecol Cancer 20:16–22CrossRefPubMed
38.
go back to reference Giles JR, Shivaprasad HL, Johnson PA (2004) Ovarian tumor expression of an oviductal protein in the hen: a model for human serous ovarian adenocarcinoma. Gynecol Oncol 95:950–953CrossRef Giles JR, Shivaprasad HL, Johnson PA (2004) Ovarian tumor expression of an oviductal protein in the hen: a model for human serous ovarian adenocarcinoma. Gynecol Oncol 95:950–953CrossRef
39.
go back to reference Hudson LG, Zeineldin R, Stack MS (2008) Phenotypic plasticity of neoplastic ovarian epithelium: unique cadherin profiles in tumor progression. Clin Exp Metastasis 25:643–655CrossRefPubMed Hudson LG, Zeineldin R, Stack MS (2008) Phenotypic plasticity of neoplastic ovarian epithelium: unique cadherin profiles in tumor progression. Clin Exp Metastasis 25:643–655CrossRefPubMed
40.
go back to reference Morin PJ (2005) Claudin proteins in human cancer: promising new targets for diagnosis and therapy. Cancer Res 65:9603–9606CrossRefPubMed Morin PJ (2005) Claudin proteins in human cancer: promising new targets for diagnosis and therapy. Cancer Res 65:9603–9606CrossRefPubMed
Metadata
Title
Gene Expression Profiling Reveals Differentially Expressed Genes in Ovarian Cancer of the Hen: Support for Oviductal Origin?
Authors
Lindsey S. Treviño
James R. Giles
Wei Wang
Mary Ellen Urick
Patricia Ann Johnson
Publication date
01-08-2010
Publisher
Springer-Verlag
Published in
Discover Oncology / Issue 4/2010
Print ISSN: 1868-8497
Electronic ISSN: 2730-6011
DOI
https://doi.org/10.1007/s12672-010-0024-8

Other articles of this Issue 4/2010

Discover Oncology 4/2010 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine